An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

Author: Weinberg J.M.  

Publisher: Elsevier

ISSN: 0149-2918

Source: Clinical Therapeutics, Vol.25, Iss.10, 2003-10, pp. : 2487-2505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next